key: cord-0071654-q3le24i8 authors: Tomšič, Nejc; Tomšič, Matija; Rotar, Žiga; Hočevar, Alojzija; Savevski, Victor; Selmi, Carlo F. title: The impact of the COVID-19 pandemic on the global assessments of rheumatology clinimetrics: Data from a mobile application. A comment on article by Nagy E, et al.: “The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned” date: 2021-12-15 journal: Autoimmun Rev DOI: 10.1016/j.autrev.2021.103020 sha: 0b0d7f1ce966949f833e8007417a49fca2c684f5 doc_id: 71654 cord_uid: q3le24i8 nan The impact of the COVID-19 pandemic on the global assessments of rheumatology clinimetrics: Data from a mobile application. A comment on article by Nagy E, et al.: "The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned" We read the article by Nagy E, et al., titled "The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned" with great interest [1] . We have observed a very similar impact of the pandemic on the usage of mobile application RheumaHelper for rheumatologists. RheumaHelper is currently used by more than 8000 physicians in 110 countries. Among the clinical tools provided in the application, the Disease Activity Score 28 (DAS28) calculator is among the most popular. DAS28 is a composite measure of disease activity of rheumatoid arthritis (RA) and is recommended as one of the tools to follow the treat-to-target strategy in RA patients [2] . As the calculation of DAS28 requires the assessment of tender and swollen joint counts by a healthcare professional, DAS28 may be considered a surrogate marker of outpatient visits for RA patients. Anonymous DAS28 calculator usage counts were collected between January 2019 and December 2020 with an analytics solution provided by Mixpanel. We have analyzed cumulative global data and data for countries with the highest monthly DAS28 calculator use in the prepandemic year 2019. We chose countries with over 400 uses per month: Argentina, Brazil, China, India, Italy, Malaysia, Mexico, Romania, the Russian Federation, Spain, and the United Kingdom. Globally, the number of DAS28 calculations was reduced by 46.8% in the first COVID-19 wave and by 36.5% in the second wave. In the group of countries with the highest number of DAS28 calculations the median reduction was 51.3% (IQR 34.6-57.6), ranging from 12.7% (the Russian Federation) to 71.7% (Romania) during the first COVID-19 wave (March to May 2020), while during the second pandemic wave (October 2020 to December 2020) the median reduction was 53.4% (IQR 40.5-62.1), ranging from 8.6% (the Russian Federation) to 64.8% (Mexico). The monthly counts of DAS28 calculations in 2019 and 2020 are shown in Fig. 1 [3] . Interestingly, we have noticed that the median reduction was higher during the first pandemic wave in European countries (57.3% vs. 51.9%), but in the non-European countries the reduction was higher during the second wave (45% vs. 57.1% for first and second wave, respectively). In conclusion, the novel approach of using the number of DAS28 calculations stratified by country as a proxy for rheumatology outpatient visits led to similar observations as the more conventional approach of assessing the impact of the COVID-19 pandemic on the access to rheumatology services. This study was funded by the Slovenian Research Agency (ARRS) for the National Research Program P3-0314. The research did not involve human participants, human tissue and/ or personal data and therefore qualifies as an exemption for obtaining an ethics committee approval. Nejc Tomšič is a co-founder of the software company that has developed the RheumaHelper mobile application. Ž iga Rotar and Matija Tomšič have been providing expert advice for the development of the RheumaHelper application. The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: a lesson to be learned Treating rheumatoid arthritis to target: recommendations of an international task force Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review